Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Idarubicin + antithymocyte globulin conditioning in sibling donor allo-HSCT for standard-risk acute leukemia
ChiCTR-OIN-16007780Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- Jan 2016
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of idarubicin and antithymocyte globulin in Acute Leukaemia, sponsored by The First Affiliated Hospital of Guangxi Medical University. Started Jan 2016; status: recruiting.
02
Drugs
idarubicinantithymocyte globulin
03
Conditions
Acute Leukaemia
Beyond the preview
Go deeper on ChiCTR-OIN-16007780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OIN-16007780.